Dr. Sanjay Juneja interviews David Hysong and Katherine Arline from Shepherd, a precision oncology platform. They discuss the limitations of traditional cancer treatment guidelines and the need for a more personalized approach. Shepherd uses multiomic data, including RNA sequencing, to assess a patient's unique tumor characteristics and recommend tailored therapies. They also consider collateral medications and potential side effects.
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
